Q-linea Future Growth
Future criteria checks 2/6
Q-linea is forecast to grow earnings and revenue by 47.9% and 51.1% per annum respectively. EPS is expected to grow by 67% per annum. Return on equity is forecast to be -105.3% in 3 years.
Key information
47.9%
Earnings growth rate
67.0%
EPS growth rate
| Medical Equipment earnings growth | 36.6% |
| Revenue growth rate | 51.1% |
| Future return on equity | -105.3% |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 108 | -67 | -63 | -53 | 1 |
| 12/31/2025 | 149 | -138 | -88 | -81 | 2 |
| 12/31/2024 | 49 | -218 | -194 | -187 | 2 |
| 9/30/2024 | 3 | -218 | -199 | -190 | N/A |
| 6/30/2024 | 7 | -225 | -204 | -195 | N/A |
| 3/31/2024 | 8 | -224 | -212 | -204 | N/A |
| 12/31/2023 | 6 | -229 | -237 | -229 | N/A |
| 9/30/2023 | 6 | -239 | -268 | -260 | N/A |
| 6/30/2023 | 5 | -249 | -269 | -259 | N/A |
| 3/31/2023 | 8 | -257 | -288 | -273 | N/A |
| 12/31/2022 | 14 | -269 | -268 | -251 | N/A |
| 9/30/2022 | 18 | -256 | -276 | -256 | N/A |
| 6/30/2022 | 16 | -246 | -288 | -266 | N/A |
| 3/31/2022 | 16 | -241 | -260 | -243 | N/A |
| 12/31/2021 | 10 | -231 | -261 | -249 | N/A |
| 9/30/2021 | 6 | -237 | -248 | -241 | N/A |
| 6/30/2021 | 5 | -236 | -231 | -225 | N/A |
| 3/31/2021 | 1 | -226 | -242 | -234 | N/A |
| 12/31/2020 | 1 | -219 | -251 | -237 | N/A |
| 9/30/2020 | 0 | -224 | -228 | -213 | N/A |
| 6/30/2020 | 0 | -210 | -218 | -202 | N/A |
| 3/31/2020 | 1 | -197 | -201 | -188 | N/A |
| 12/31/2019 | 1 | -177 | -177 | -170 | N/A |
| 9/30/2019 | 1 | -155 | -160 | -155 | N/A |
| 6/30/2019 | 2 | -149 | -153 | -151 | N/A |
| 3/31/2019 | 1 | -141 | -140 | -138 | N/A |
| 12/31/2018 | 1 | -128 | -124 | -123 | N/A |
| 9/30/2018 | 2 | -111 | -108 | -106 | N/A |
| 6/30/2018 | 2 | -97 | N/A | -89 | N/A |
| 12/31/2017 | 2 | -68 | N/A | -63 | N/A |
| 12/31/2016 | 0 | -60 | N/A | -53 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QLINEA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: QLINEA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: QLINEA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: QLINEA's revenue (51.1% per year) is forecast to grow faster than the Swedish market (-0.03% per year).
High Growth Revenue: QLINEA's revenue (51.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: QLINEA is forecast to be unprofitable in 3 years.